BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 33219675)

  • 1. Hydroxychloroquine pre-exposure prophylaxis for COVID-19 in healthcare workers.
    Revollo B; Tebe C; Peñafiel J; Blanco I; Perez-Alvarez N; Lopez R; Rodriguez L; Ferrer J; Ricart P; Moret E; Tural C; Carreres A; Matllo J; Videla S; Clotet B; Llibre JM
    J Antimicrob Chemother; 2021 Feb; 76(3):827-829. PubMed ID: 33219675
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of hydroxychloroquine for pre-exposure prophylaxis in COVID 19: debate and suggested future course.
    Agarwal M; Ranjan P; Mittal A; Baitha U
    Expert Rev Anti Infect Ther; 2021 Apr; 19(4):413-417. PubMed ID: 32981388
    [No Abstract]   [Full Text] [Related]  

  • 3. Hydroxychloroquine pre-exposure prophylaxis provides no protection against COVID-19 among health care workers: a cross-sectional study in a tertiary care hospital in North India.
    Juneja S; Rana P; Chawla P; Katoch R; Singh K; Rana S; Mittal T; Kaur B; Kaur S
    J Basic Clin Physiol Pharmacol; 2022 Jan; 33(1):103-107. PubMed ID: 34995022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sharing experience: Hydroxychloroquine in preexposure prophylaxis against COVID-19.
    Kulkarni C; Sadiq A; Gigi A; Devassia A; George G
    Indian J Pharmacol; 2021; 53(5):420-421. PubMed ID: 34854415
    [No Abstract]   [Full Text] [Related]  

  • 5. Finding the Dose for Hydroxychloroquine Prophylaxis for COVID-19: The Desperate Search for Effectiveness.
    Al-Kofahi M; Jacobson P; Boulware DR; Matas A; Kandaswamy R; Jaber MM; Rajasingham R; Young JH; Nicol MR
    Clin Pharmacol Ther; 2020 Oct; 108(4):766-769. PubMed ID: 32344449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial.
    Grau-Pujol B; Camprubí D; Marti-Soler H; Fernández-Pardos M; Guinovart C; Muñoz J
    Trials; 2020 Jul; 21(1):688. PubMed ID: 32727613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection?
    Mehta S; Bhandari S; Mehta S
    J Glob Antimicrob Resist; 2020 Sep; 22():864-865. PubMed ID: 32777441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous ozonized saline therapy as prophylaxis for healthcare workers (HCWs) in a dedicated COVID-19 hospital in India - A retrospective study.
    Sharma A; Shah M; Sane H; Gokulchandran N; Paranjape A; Khubchandani P; Captain J; Shirke S; Kulkarni P
    Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3632-3639. PubMed ID: 34002840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada.
    Wright JK; Tan DHS; Walmsley SL; Hulme J; O'Connor E; Snider C; Cheng I; Chan AK; Borgundvaag B; McLeod S; Gollob MH; Clarke RJ; Dresser L; Haji F; Mazzulli T; Mubareka S; Jüni P; Lee D; Tomlinson G; Kain KC; Landes M
    Trials; 2020 Jul; 21(1):647. PubMed ID: 32665039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial.
    Abella BS; Jolkovsky EL; Biney BT; Uspal JE; Hyman MC; Frank I; Hensley SE; Gill S; Vogl DT; Maillard I; Babushok DV; Huang AC; Nasta SD; Walsh JC; Wiletyo EP; Gimotty PA; Milone MC; Amaravadi RK;
    JAMA Intern Med; 2021 Feb; 181(2):195-202. PubMed ID: 33001138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine as pre-exposure prophylaxis against COVID-19 infection among healthcare workers: a prospective cohort study.
    Rao A; Veluswamy SK; Shankarappa BG; Reddy RM; Umesh N; John L; Mathew L; Shetty N
    Expert Rev Anti Infect Ther; 2022 May; 20(5):781-787. PubMed ID: 34865592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recrudescence of Sarcoidosis on stopping Hydroxychloroquine pre-contact prophylaxis for COVID-19.
    Ganesan D; Griffiths S; O'Regan A; Breen D; Rutherford RM
    Ir Med J; 2024 May; 117(5):962. PubMed ID: 38801145
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report.
    Kauv J; Lê MP; Veyrier M; Le Hingrat Q; Visseaux B; Massias L; Chauveheid MP; Descamps D; Ghosn J; Peytavin G
    J Antimicrob Chemother; 2020 Sep; 75(9):2706-2707. PubMed ID: 32457980
    [No Abstract]   [Full Text] [Related]  

  • 14. Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial.
    Rajasingham R; Bangdiwala AS; Nicol MR; Skipper CP; Pastick KA; Axelrod ML; Pullen MF; Nascene AA; Williams DA; Engen NW; Okafor EC; Rini BI; Mayer IA; McDonald EG; Lee TC; Li P; MacKenzie LJ; Balko JM; Dunlop SJ; Hullsiek KH; Boulware DR; Lofgren SM;
    Clin Infect Dis; 2021 Jun; 72(11):e835-e843. PubMed ID: 33068425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine Pre-Exposure Prophylaxis for COVID-19 in Healthcare Workers from India: A Meta-Analysis.
    Stricker RB; Fesler MC
    J Infect Public Health; 2021 Sep; 14(9):1161-1163. PubMed ID: 34391171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemic.
    Gagneux-Brunon A; Schilte C; Garcin A; Jolly N; Vray M; Schaeffer L; Duval X; Hoen B; Botelho-Nevers E
    Trials; 2021 May; 22(1):373. PubMed ID: 34053460
    [No Abstract]   [Full Text] [Related]  

  • 17. System for administering and monitoring hydroxychloroquine prophylaxis for COVID-19 in accordance with a national advisory: preliminary experience of a tertiary care institute in India.
    Kumar-M P; Mohindra R; Bhalla A; Shafiq N; Suri V; Kumari D; Pandey AK; Gupta A; Gupta PC; Patil A; Kakkar AK; Malhotra S
    Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1331-1339. PubMed ID: 33781166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarials are not Effective as Pre-Exposure Prophylaxis for COVID-19: A Retrospective Matched Control Study.
    Klebanov N; Pahalyants V; Said JT; Murphy WS; Theodosakis N; Scarry J; Duey S; Klevens M; Lilly E; Semenov YR
    J Drugs Dermatol; 2023 Aug; 22(8):840-843. PubMed ID: 37556518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxychloroquine for prophylaxis of COVID-19 in health workers: A randomized clinical trial.
    Rojas-Serrano J; Portillo-Vásquez AM; Thirion-Romero I; Vázquez-Pérez J; Mejía-Nepomuceno F; Ramírez-Venegas A; Pérez-Kawabe KM; Pérez-Padilla R
    PLoS One; 2022; 17(2):e0261980. PubMed ID: 35139097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ).
    Naggie S; Milstone A; Castro M; Collins SP; Lakshmi S; Anderson DJ; Cahuayme-Zuniga L; Turner KB; Cohen LW; Currier J; Fraulo E; Friedland A; Garg J; George A; Mulder H; Olson RE; O'Brien EC; Rothman RL; Shenkman E; Shostak J; Woods CW; Anstrom KJ; Hernandez AF;
    Int J Infect Dis; 2023 Apr; 129():40-48. PubMed ID: 36682681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.